QUALITY-OF-LIFE ASSESSMENT IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION OR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

被引:73
|
作者
HAMER, ME
BLUMENTHAL, JA
MCCARTHY, EA
PHILLIPS, BG
PRITCHETT, ELC
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DIV CLIN PHARMACOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT MED,DIV CARDIOL,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT PSYCHIAT,DIV MED PSYCHOL,DURHAM,NC 27710
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1994年 / 74卷 / 08期
关键词
D O I
10.1016/0002-9149(94)90448-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paroxysmal atrial fibrillation (AF) and paroxysmal supraventricular tachycardia (SVT) are common supraventricular arrhythmias. Patients with these arrhythmias report symptoms of palpitations, dizziness, dyspnea, and diaphoresis during episodes of these tachycardias, and they are often treated with antiarrhythmic drugs to reduce symptomatic recurrences.1 Interventional catheterization and surgical procedures are available to patients who remain disabled despite antiarrhythmic therapy.2-4 Despite the prevalence of patients with these disorders and the expense and risk of the therapies used, little is known about how patients perceive disability due to these disorders and what coping strategies they use during recurrences of their arrhythmias. The purpose of this study was, therefore, to assess functional disability and coping strategies in patients with well-characterized attacks of paroxysmal AF or paroxysmal SVT. © 1994.
引用
收藏
页码:826 / 829
页数:4
相关论文
共 50 条
  • [41] ATRIAL NATRIURETIC PEPTIDE IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
    TIKKANEN, I
    METSARINNE, K
    FYHRQUIST, F
    LANCET, 1985, 2 (8445): : 40 - 41
  • [42] ACEBUTOLOL IN THE THERAPY OF PAROXYSMAL ATRIAL-FIBRILLATION
    BONATTI, V
    FAVARO, L
    BOTTI, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1982, 2 (04) : 47 - 55
  • [43] PAROXYSMAL ATRIAL-FIBRILLATION - A NEED FOR CLASSIFICATION
    LEVY, S
    NOVELLA, P
    RICARD, P
    PAGANELLI, F
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1995, 6 (01) : 69 - 74
  • [44] Ibutilide for paroxysmal atrial fibrillation cardioversion during supraventricular tachycardia radiofrequency ablation
    Vassilikos, V
    Paraskevaidis, S
    EUROPEAN HEART JOURNAL, 2004, 25 : 491 - 491
  • [45] MANAGEMENT OF PAROXYSMAL ATRIAL-FIBRILLATION - REPLY
    LIP, GYH
    METCALFE, MJ
    RAE, AP
    QUARTERLY JOURNAL OF MEDICINE, 1993, 86 (10): : 691 - 692
  • [46] ISOLATED ATTACKS OF PAROXYSMAL ATRIAL-FIBRILLATION
    不详
    BRITISH MEDICAL JOURNAL, 1973, 3 (5881): : 630 - 630
  • [47] HEMODYNAMICS OF IDIOPATHIC PAROXYSMAL ATRIAL-FIBRILLATION
    ALBONI, P
    SCARFO, S
    FUCA, G
    PAPARELLA, N
    YANNACOPULU, P
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (05): : 980 - 985
  • [48] AJMALINE IN THE TREATMENT OF PAROXYSMAL ATRIAL-FIBRILLATION
    PERESECENSCHI, G
    EIDELMAN, B
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (04): : 483 - 488
  • [49] Association between Paroxysmal Supraventricular Tachycardia and Ischemic Stroke in Patients Without Atrial Fibrillation.
    Kamel, Hooman
    Gladstone, David
    Turakhia, Mintu
    Healey, Jeff
    Elkind, Mitchell
    Karas, Maria
    Okin, Peter
    Iadecola, Costantino
    STROKE, 2016, 47
  • [50] ANTITHROMBOTIC THERAPY IN PAROXYSMAL ATRIAL-FIBRILLATION
    DUNN, MI
    STARR, SK
    CHEST, 1994, 105 (03) : 972 - 972